What is the recommended Penicillin V potassium dosage for secondary prophylaxis of rheumatic heart disease in adults and in children based on weight?

Penicillin V Potassium Dosing for RHD Secondary Prophylaxis

For secondary prophylaxis of rheumatic heart disease, the recommended dose of Penicillin V potassium is 250 mg twice daily for both children and adults, regardless of weight. 111

Dosing Specifics

The American Heart Association guidelines provide a Class I, Level of Evidence B recommendation for this uniform dosing regimen:

• Adults: 250 mg orally twice daily
• Children: 250 mg orally twice daily (same dose as adults)
• No weight-based adjustment is recommended for RHD prophylaxis 111

This differs from the FDA labeling for other indications, which lists a range of 125-250 mg twice daily for general prevention of rheumatic fever recurrence 2. However, the AHA guideline specifically recommends the 250 mg dose for both populations.

Important Clinical Considerations

Intramuscular vs. Oral Penicillin

Intramuscular benzathine penicillin G remains superior to oral penicillin for secondary prophylaxis. Even with optimal adherence, oral prophylaxis carries a higher risk of rheumatic fever recurrence compared to IM benzathine penicillin G 111.

Oral agents are most appropriate for:

• Patients at lower risk for rheumatic fever recurrence
• Late adolescents or young adults who have remained attack-free for at least 5 years (Class IIb recommendation) 111

Critical Adherence Warning

The primary cause of prophylaxis failure is non-adherence, not drug ineffectiveness 111. Patients require repeated, careful instruction about the critical importance of continuing prophylaxis. Recent meta-analysis confirms that good adherence reduces ARF recurrence or RHD progression by 71% 3.

Penicillin Allergy Alternatives

For penicillin-allergic patients:

• Sulfadiazine (Class I, LOE B):

  • 0.5 g once daily if ≤27 kg (60 lbs)
  • 1 g once daily if >27 kg 111

• Macrolides/Azalides (Class I, LOE C) if allergic to both penicillin and sulfonamides:

  • Erythromycin, clarithromycin, or azithromycin
  • Caution: QT prolongation risk and cytochrome P-450 3A interactions 111

Storage and Preparation

When using oral solution formulation:

• Must be refrigerated after reconstitution
• Discard unused portion after 14 days
• 250 mg/5 mL concentration provides 400,000 units per teaspoonful 22